查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1611182

美國動物保健市場規模、佔有率和趨勢分析報告：按動物類型、產品、疫苗類型、疾病、給藥途徑、分銷管道和細分市場進行預測（2025-2030）

U.S. Animal Health Market Size, Share & Trends Analysis Report By Animal Type (Production Animal, Companion Animal), By Product, By Type Of Vaccine, By Disease, By Route Of Administration, By Distribution Channel, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 150 Pages | 商品交期: 2-10個工作天內

價格

美國動物保健市場的成長與趨勢：

Grand View Research, Inc.最新報告顯示，到2030年，美國動物保健市場規模預計將達到197.7億美元，2025年至2030年複合年成長率為7.97%。

這個市場主要是由動物數量和飼養率的增加、動物支出的增加、對預防性動物保健的日益關注、動物用藥品學的進步以及由於研發投資增加而推出的創新產品所推動的。例如，2024年11月，Bimeda推出了MoxiSolv注射液（莫昔克丁），這是一種FDA批准的用於肉牛和非泌乳牛的寄生蟲殺蟲劑，裝在方便、防濺的500mL塑膠瓶中。

此外，通用感染疾病的增加、牲畜數量的增加、對預防性醫療保健的興趣增加以及牲畜支出的增加也推動了該行業。美國畜牧業人口不斷增加，用於肉類生產的牛、羊、豬和家禽數量大幅增加。例如，根據世界市場與貿易報告、美國對外農業服務局畜禽報告顯示，截至2024年1月，美國牛隻存欄量為8,780萬頭，豬隻存欄量為7,497萬頭。這些大量的牲畜需要全面的獸醫護理和醫療干預，以保持它們的健康和生產力。

此外，畜牧業每年帶來超過 700 億美元的經濟重要性，促使相關人員優先考慮健康管理，以減少疾病造成的潛在損失。消費者對優質牛肉和乳製品的需求不斷增加，以及對永續農業實踐的認知不斷提高，也在牛健康管理解決方案的採用中發揮關鍵作用。政府支持的措施和加強農村地區獸醫服務正在進一步加強該部門並確保其持續擴張。

此外，藥物飼料添加劑的核准增加也透過改善牲畜健康和生產效率來顯著推動市場。例如，2024年6月，FDA核准Elanco的減少甲烷排放的飼料添加劑Bovaer（3-NOP）用於泌乳牛。 Bovaer 每頭牛可減少 30% 的甲烷排放，這意味著如果 100 萬牛使用，每年可減少的排放相當於減少 285,000 輛汽車的排放量。這項創新透過碳市場為酪農提供經濟獎勵，支持永續努力並實現全球氣候目標。 Elanco 將與帝斯曼芬美意合作，在整個北美地區分銷 Bovaer，為永續農業實踐和乳製品產業的競爭力做出貢獻。

同樣，動物用藥品的快速發展也為該行業創造了利潤豐厚的機會。動物用藥品的開發導致了針對多種動物疾病和疾病的更強化和更有效的治療方法的開發。此外，對創新動物用藥品的需求是由新藥物和治療方法可以為動物帶來更好的結果，減少副作用並提高療效。例如，2024年9月，默克動物保健公司推出NOBIVAC NXT FeLV，這是第一個針對貓白血病病毒（FeLV）的RNA疫苗，擴大了其NOBIVAC NXT疫苗平台。這種創新疫苗針對 FeLV（一種常見的貓科動物感染疾病）提供了最佳保護，並將在全國獸醫診所提供。同樣，2024 年 6 月，Bimeda 推出了氟米松 Bimasone，這是 FDA核准的第一個用於治療馬、狗和貓發炎和過敏性疾病的學名藥。

美國動物保健市場報告亮點

  • 依產品分類，2024年醫藥領域的銷售佔有率最高。然而，生技藥品領域預計在預測期內將以最快的複合年成長率成長。
  • 按動物分類，由於通用感染疾病的增加、牲畜數量的增加、對預防醫學的興趣增加以及動物支出的增加，到 2024 年，生產動物部分將佔最大佔有率。
  • 按疫苗類型分類，牛疫苗預計將在 2024 年佔據市場主導地位，並在預測期內以 9.52% 的複合年成長率實現最快成長。
  • 從給藥途徑來看，2024 年口服藥物在市佔率中佔據主導地位。這一成長歸因於產業參與者推出咀嚼片等新產品。然而，局部給藥領域預計在預測期內成長最快，複合年成長率為 9.13%。

目錄

第1章調查方法與範圍

第 2 章執行摘要

第3章美國動物保健市場變數、趨勢與範圍

  • 市場體系展望
    • 母市場展望
    • 相關/輔助市場展望
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
    • 市場機會分析
    • 市場問題分析
  • 美國動物保健市場分析工具
    • 波特的分析
    • PESTEL分析
  • COVID-19 分析
  • 主要國家的寵物估計數量

第4章美國動物保健市場：動物類型的估計與趨勢分析

  • 細分儀表板
  • 美國動物保健品市場波動分析
  • 美國動物保健市場規模與趨勢分析：按動物類型（2018-2030）
    • 生產動物
    • 寵物

第5章美國動物保健市場：產品估算與趨勢分析

  • 細分儀表板
  • 美國動物保健品市場波動分析
  • 美國動物保健市場規模與趨勢分析：按產品（2018-2030）
    • 生物製藥
    • 藥品
    • 藥物飼料添加劑

第6章美國動物保健市場：疫苗種類預估及趨勢分析

  • 細分儀表板
  • 美國動物保健品市場波動分析
  • 美國動物保健市場規模與趨勢分析：依疫苗類型（2018-2030）
    • 牛疫苗
    • 豬疫苗
    • 家禽疫苗
    • 水產養殖疫苗
    • 其他疫苗

第7章美國動物保健市場：疾病估計與趨勢分析

  • 細分儀表板
  • 美國動物保健品市場波動分析
  • 美國動物保健市場規模及趨勢分析：依疾病分類（2018-2030）
    • 牛疾病
    • 豬病
    • 家禽疾病
    • 水產養殖相關疾病
    • 其他疾病

第8章美國動物保健市場：給藥途徑預估及趨勢分析

  • 細分儀表板
  • 美國動物保健品市場波動分析
  • 美國動物保健市場規模與趨勢分析：依給藥途徑分類（2018-2030）
    • 口服
    • 注射
    • 局部的
    • 其他

第9章美國動物保健市場：通路估算與趨勢分析

  • 細分儀表板
  • 美國動物保健品市場波動分析
  • 美國動物保健市場規模及趨勢分析：依通路分類（2018-2030）
    • 零售
    • 電子商務
    • 醫院/診所藥房

第10章競爭格局

  • 市場參與企業分類
  • 企業市場分析/熱圖分析
  • 策略規劃
    • 併購
    • 夥伴關係與協作
    • 其他
  • 公司簡介
    • Zoetis Inc.
    • Ceva Sante Animale
    • Merck &Co., Inc.
    • Vetoquinol SA
    • Boehringer Ingelheim Gmbh
    • Elanco Animal Health Incorporated
    • Virbac
    • Phibro Animal Health Corporation
    • Dechra Pharmaceuticals Plc
    • Bimeda, Inc.
    • Cargill, Incorporated.
    • Aurora Pharmaceutical, Inc.
    • Calier

第11章 要點

Product Code: GVR-4-68040-492-5

U.S. Animal Health Market Growth & Trends:

The U.S. animal health market size is expected to reach USD 19.77 billion by 2030, registering a CAGR of 7.97% from 2025 to 2030, according to a new report by Grand View Research, Inc. The market is primarily driven by growing animal population and ownership rates, increased expenditure on animals, an increasing focus on preventative animal healthcare, advances in veterinary medicine, and rising R&D investment in veterinary pharmaceuticals to launch innovative products. For instance, in November 2024, Bimeda launched MoxiSolv Injection (moxidectin), an FDA-approved parasiticide for beef and non-lactating dairy cattle, in a convenient, non-shattering 500 mL plastic bottle.

Furthermore, the industry is also driven by rising incidences of zoonotic diseases, increased livestock population, growing focus on preventive care, and growing animal expenditure. The livestock population in the U.S. has increased, with significant growth in cattle, sheep, pigs, and poultry being raised for meat production. For instance, as of January 2024, the U.S. had 87.8 million cattle and 74.97 million swine stock, according to the U.S. Foreign Agricultural Service's Livestock and Poultry: World Markets and Trade report. This substantial livestock population necessitates comprehensive veterinary care and medical interventions to maintain health and productivity.

In addition, the economic significance of the cattle industry, which contributes over USD 70 billion annually, has driven stakeholders to prioritize health management to mitigate potential losses due to diseases. The rising consumer demand for high-quality beef and dairy products and growing awareness of sustainable farming practices have also played a crucial role in adopting health management solutions for cattle. Government-backed initiatives and enhanced veterinary services in rural areas further strengthen the sector, ensuring its continued expansion.

Additionally, increasing approval of medicated feed additives significantly drives the market by improving livestock health and production efficiency. For instance, in June 2024, The FDA approved Elanco's methane-reducing feed additive, Bovaer (3-NOP), for lactating dairy cattle. Bovaer can reduce methane emissions by 30% per cow, potentially lowering emissions equivalent to removing 285,000 cars from the road annually if used by one million cows. This innovation offers financial incentives for dairy farmers through carbon markets, supporting sustainability efforts and meeting global climate goals. In partnership with dsm-Firmenich, Elanco will market Bovaer across North America, contributing to sustainable farming practices and enhancing the dairy industry's competitiveness.

Similarly, rapid advancements in veterinary medicine present lucrative opportunities in the industry. Improvements in animal pharmaceuticals result in the development of more focused and efficient therapies for many kinds of animal illnesses and ailments. Furthermore, the demand for innovative veterinary medications is being driven by new drugs and therapies that provide better results for animals, decreased side effects, and increased efficacy. For instance, in September 2024, Merck Animal Health expanded its NOBIVAC NXT vaccine platform by launching NOBIVAC NXT FeLV, the first RNA vaccine for feline leukemia virus (FeLV). This innovative vaccine offers optimized protection against FeLV, a common feline infectious disease, and is expected to be available at veterinary clinics nationwide. Similarly, in June 2024, Bimeda launched Bimasone, the first FDA-approved generic flumethasone, used to treat inflammation and allergic conditions in horses, dogs, and cats.

U.S. Animal Health Market Report Highlights:

  • Based on product, the pharmaceuticals segment accounted for the highest revenue share in 2024. However, the biologics segment is anticipated to grow at the fastest CAGR over the forecast period.
  • Based on animals, the production animal segment held the largest share in 2024 owing to rising incidences of zoonotic diseases, increased livestock population, growing focus on preventive care, and increased animal expenditure.
  • Based on the type of vaccine, the cattle vaccine segment dominated the market in 2024, and it is expected to grow fastest with a CAGR of 9.52% over the forecast period.
  • Based on the route of administration, the oral segment dominated the market with a share in 2024. This growth can be attributed to new product launches such as chewable tablets by the industry players. However, the topical segment is anticipated to grow at the fastest CAGR of 9.13% over the forecast period.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
    • 1.1.1. Scope
    • 1.1.2. Estimates And Forecast Timeline
  • 1.2. Market Definitions
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased Database
    • 1.4.2. GVR's Internal Database
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
    • 1.6.1. Commodity flow analysis
    • 1.6.2. Global Market: CAGR Calculation
  • 1.7. Research Scope and Assumptions
    • 1.7.1. List of Secondary Sources
    • 1.7.2. List of Primary Sources
    • 1.7.3. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. U.S. Animal Health Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Drivers Analysis
      • 3.2.1.1. Rising Prevalence of Animal Diseases
      • 3.2.1.2. Growing Uptake Of Pet Insurance
      • 3.2.1.3. Increase In Pet Population & Pet Humanization
    • 3.2.2. Market Restraints Analysis
      • 3.2.2.1. High cost of treatment
      • 3.2.2.2. Adverse effects associated with therapies
    • 3.2.3. Market Opportunity Analysis
    • 3.2.4. Market Challenges Analysis
  • 3.3. U.S. Animal Health Market Analysis Tools
    • 3.3.1. Porter's Analysis
      • 3.3.1.1. Bargaining power of the suppliers
      • 3.3.1.2. Bargaining power of the buyers
      • 3.3.1.3. Threats of substitution
      • 3.3.1.4. Threats from new entrants
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Economic and Social Landscape
      • 3.3.2.3. Technological landscape
      • 3.3.2.4. Environmental Landscape
      • 3.3.2.5. Legal landscape
  • 3.4. Covid-19 Analysis
  • 3.5. Estimated Pet Population by key countries

Chapter 4. U.S. Animal Health Market: Animal Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. U.S. Animal Health Market Movement Analysis
  • 4.3. U.S. Animal Health Market Size & Trend Analysis, by Animal, 2018 to 2030 (USD Million)
    • 4.3.1. Production Animals
      • 4.3.1.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 4.3.1.2. Poultry
        • 4.3.1.2.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 4.3.1.3. Swine
        • 4.3.1.3.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 4.3.1.4. Cattles
        • 4.3.1.4.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 4.3.1.5. Sheep & Goats
        • 4.3.1.5.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 4.3.1.6. Fish
        • 4.3.1.6.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.3.2. Companion Animals
      • 4.3.2.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 4.3.2.2. Dogs
        • 4.3.2.2.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 4.3.2.3. Cats
        • 4.3.2.3.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 4.3.2.4. Horses
        • 4.3.2.4.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 4.3.2.5. Others
        • 4.3.2.5.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. U.S. Animal Health Market: Product Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. U.S. Animal Health Market Movement Analysis
  • 5.3. U.S. Animal Health Market Size & Trend Analysis, by Product, 2018 to 2030 (USD Million)
    • 5.3.1. Biologics
      • 5.3.1.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 5.3.1.2. Vaccines
        • 5.3.1.2.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
        • 5.3.1.2.2. Attenuated Live Vaccines
          • 5.3.1.2.2.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
        • 5.3.1.2.3. Inactivated Vaccines
          • 5.3.1.2.3.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
        • 5.3.1.2.4. Subunit Vaccines
          • 5.3.1.2.4.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
        • 5.3.1.2.5. DNA Vaccines
          • 5.3.1.2.5.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
          • 5.3.1.2.5.2. Recombinant Vaccines
          • 5.3.1.2.5.3. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
          • 5.3.1.2.5.4. Autogenous Vaccines
          • 5.3.1.2.5.5. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
          • 5.3.1.2.5.6. Other Biologics
          • 5.3.1.2.5.7. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.3.2. Pharmaceuticals
      • 5.3.2.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 5.3.2.2. Parasiticides
        • 5.3.2.2.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 5.3.2.3. Anti-infectives
        • 5.3.2.3.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 5.3.2.4. Anti-inflammatory
        • 5.3.2.4.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 5.3.2.5. Analgesics
        • 5.3.2.5.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 5.3.2.6. Other Pharmaceuticals
        • 5.3.2.6.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.3.3. Medicinal Feed Additives
      • 5.3.3.1. Market estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 6. U.S. Animal Health Market: Type of Vaccine Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. U.S. Animal Health Market Movement Analysis
  • 6.3. U.S. Animal Health Market Size & Trend Analysis, by Type of Vaccine, 2018 to 2030 (USD Million)
    • 6.3.1. Cattle Vaccine
      • 6.3.1.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.3.2. Porcine Vaccine
      • 6.3.2.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.3.3. Poultry Vaccine
      • 6.3.3.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.3.4. Aquaculture Vaccine
      • 6.3.4.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.3.5. Other Vaccines
      • 6.3.5.1. Market estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 7. U.S. Animal Health Market: Disease Estimates & Trend Analysis

  • 7.1. Segment Dashboard
  • 7.2. U.S. Animal Health Market Movement Analysis
  • 7.3. U.S. Animal Health Market Size & Trend Analysis, by Disease, 2018 to 2030 (USD Million)
    • 7.3.1. Cattle Disease
      • 7.3.1.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.3.2. Porcine Disease
      • 7.3.2.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.3.3. Poultry Disease
      • 7.3.3.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.3.4. Aquaculture Disease
      • 7.3.4.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.3.5. Other Disease
      • 7.3.5.1. Market estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 8. U.S. Animal Health Market: Route of Administration Estimates & Trend Analysis

  • 8.1. Segment Dashboard
  • 8.2. U.S. Animal Health Market Movement Analysis
  • 8.3. U.S. Animal Health Market Size & Trend Analysis, by Route of Administration, 2018 to 2030 (USD Million)
    • 8.3.1. Oral
      • 8.3.1.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
    • 8.3.2. Injectable
      • 8.3.2.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
      • 8.3.2.2. Subcutaneous
        • 8.3.2.2.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
      • 8.3.2.3. Intramuscular
        • 8.3.2.3.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
      • 8.3.2.4. Intravenous
        • 8.3.2.4.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
    • 8.3.3. Topical
      • 8.3.3.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
    • 8.3.4. Other
      • 8.3.4.1. Market estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 9. U.S. Animal Health Market: Distribution Channel Estimates & Trend Analysis

  • 9.1. Segment Dashboard
  • 9.2. U.S. Animal Health Market Movement Analysis
  • 9.3. U.S. Animal Health Market Size & Trend Analysis, by Distribution Channel, 2018 to 2030 (USD Million)
    • 9.3.1. Retail
      • 9.3.1.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
    • 9.3.2. E-Commerce
      • 9.3.2.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
    • 9.3.3. Hospital/ Clinic Pharmacy
      • 9.3.3.1. Market estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 10. Competitive Landscape

  • 10.1. Market Participant Categorization
  • 10.2. Company Market Position Analysis/ Heat Map Analysis
  • 10.3. Strategy Mapping
    • 10.3.1. Mergers & Acquisitions
    • 10.3.2. Partnerships & Collaborations
    • 10.3.3. Others
  • 10.4. Company Profiles
    • 10.4.1. Zoetis Inc.
      • 10.4.1.1. Participant's Overview
      • 10.4.1.2. Financial Performance
      • 10.4.1.3. Product Benchmarking
      • 10.4.1.4. Strategic Initiatives
    • 10.4.2. Ceva Sante Animale
      • 10.4.2.1. Participant's Overview
      • 10.4.2.2. Financial Performance
      • 10.4.2.3. Product Benchmarking
      • 10.4.2.4. Strategic Initiatives
    • 10.4.3. Merck & Co., Inc.
      • 10.4.3.1. Participant's Overview
      • 10.4.3.2. Financial Performance
      • 10.4.3.3. Product Benchmarking
      • 10.4.3.4. Strategic Initiatives
    • 10.4.4. Vetoquinol S.A.
      • 10.4.4.1. Participant's Overview
      • 10.4.4.2. Financial Performance
      • 10.4.4.3. Product Benchmarking
      • 10.4.4.4. Strategic Initiatives
    • 10.4.5. Boehringer Ingelheim Gmbh
      • 10.4.5.1. Participant's Overview
      • 10.4.5.2. Financial Performance
      • 10.4.5.3. Product Benchmarking
      • 10.4.5.4. Strategic Initiatives
    • 10.4.6. Elanco Animal Health Incorporated
      • 10.4.6.1. Participant's Overview
      • 10.4.6.2. Financial Performance
      • 10.4.6.3. Product Benchmarking
      • 10.4.6.4. Strategic Initiatives
    • 10.4.7. Virbac
      • 10.4.7.1. Participant's Overview
      • 10.4.7.2. Financial Performance
      • 10.4.7.3. Product Benchmarking
      • 10.4.7.4. Strategic Initiatives
    • 10.4.8. Phibro Animal Health Corporation
      • 10.4.8.1. Participant's Overview
      • 10.4.8.2. Financial Performance
      • 10.4.8.3. Product Benchmarking
      • 10.4.8.4. Strategic Initiatives
    • 10.4.9. Dechra Pharmaceuticals Plc
      • 10.4.9.1. Participant's Overview
      • 10.4.9.2. Financial Performance
      • 10.4.9.3. Product Benchmarking
      • 10.4.9.4. Strategic Initiatives
    • 10.4.10. Bimeda, Inc.
      • 10.4.10.1. Participant's Overview
      • 10.4.10.2. Financial Performance
      • 10.4.10.3. Product Benchmarking
      • 10.4.10.4. Strategic Initiatives
    • 10.4.11. Cargill, Incorporated.
      • 10.4.11.1. Participant's Overview
      • 10.4.11.2. Financial Performance
      • 10.4.11.3. Product Benchmarking
      • 10.4.11.4. Strategic Initiatives
    • 10.4.12. Aurora Pharmaceutical, Inc.
      • 10.4.12.1. Participant's Overview
      • 10.4.12.2. Financial Performance
      • 10.4.12.3. Product Benchmarking
      • 10.4.12.4. Strategic Initiatives
    • 10.4.13. Calier
      • 10.4.13.1. Participant's Overview
      • 10.4.13.2. Financial Performance
      • 10.4.13.3. Product Benchmarking
      • 10.4.13.4. Strategic Initiatives

Chapter 11. Key Takeaways

List of Tables

  • Table 1 Cost of surgeries, USD
  • Table 2 Pricing analysis for vaccines (USD), 2024
  • Table 3 Estimated animal population in U.S. by key species, 2018 to 2023
  • Table 4 U.S. Animal Health Market Revenue Estimates and Forecast, By Product, 2018 - 2030 (USD Million)
  • Table 5 U.S. Animal Health Market Revenue Estimates and Forecast, By Biologics, 2018 - 2030 (USD Million)
  • Table 6 U.S. Animal Health Market Revenue Estimates and Forecast, By Vaccines, 2018 - 2030 (USD Million)
  • Table 7 U.S. Animal Health Market Revenue Estimates and Forecast, By Pharmaceuticals, 2018 - 2030 (USD Million)
  • Table 8 U.S. Animal Health Market Revenue Estimates and Forecast, By Animal Type, 2018-2030 (USD million)
  • Table 9 U.S. Animal Health Market Revenue Estimates and Forecast, By Production Animal, 2018 - 2030 (USD Million)
  • Table 10 U.S. Animal Health Market Revenue Estimates and Forecast, By Companion Animal, 2018 - 2030 (USD Million)
  • Table 11 U.S. Animal Health Market Revenue Estimates and Forecast, By Type of Vaccine, 2018 - 2030 (USD Million)
  • Table 12 U.S. Animal Health Market Revenue Estimates and Forecast, By Disease, 2018 - 2030 (USD Million)
  • Table 13 U.S. animal health market estimates and forecast, by Route of administration, 2018 - 2030 (USD Million)
  • Table 14 U.S. Animal Health Market Revenue Estimates and Forecast, By Injectables, 2018 - 2030 (USD Million)
  • Table 15 U.S. Animal Health Market Revenue Estimates and Forecast, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 16 Participants' overview
  • Table 17 Financial performance
  • Table 18 Products benchmarking
  • Table 19 Estimated Company Market Share in U.S Animal Health Market
  • Table 20 Estimated Company Market Share in U.S Animal Health Pharmaceutical Market
  • Table 21 Estimated Company Market Share in U.S Animal Health Vaccines Market
  • Table 22 Estimated Company Market Share in the U.S Animal Health Medicated Feed Additives Market
  • Table 23 Key market players initiating expansion
  • Table 24 Key market players initiating mergers & acquisitions
  • Table 25 Key market players initiating partnerships & collaborations.
  • Table 26 Key market players initiating service launches/expansions
  • Table 27 Key market players undertaking approvals
  • Table 28 Key market players undertaking other activities
  • Table 29 List of key market players

List of Figures

  • Fig. 1 Market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Data triangulation techniques
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value-chain-based sizing & forecasting
  • Fig. 7 Market formulation & validation
  • Fig. 8 General methodology for Commodity flow analysis of Animal Health market
  • Fig. 9 Commodity flow analysis
  • Fig. 10 Segment-level bottom-up approach
  • Fig. 11 Market snapshot
  • Fig. 12 Segment snapshot
  • Fig. 13 Segment snapshot
  • Fig. 14 Segment snapshot
  • Fig. 15 Competitive landscape snapshot
  • Fig. 16 Parent market analysis, 2024 (USD billion)
  • Fig. 17 Ancillary market outlook, 2024
  • Fig. 18 U.S. animal health market dynamics
  • Fig. 19 Estimated number of U.S. households owning a pet (2024)
  • Fig. 20 U.S. animal health market: PORTER's analysis
  • Fig. 21 U.S. animal health market: PESTEL analysis
  • Fig. 22 U.S. Animal Health market by product type: Key takeaways
  • Fig. 23 U.S. Animal Health market by product type market share, 2024 & 2030
  • Fig. 24 Biologics market estimates & forecasts, 2018 - 2030 (USD Million)
  • Fig. 25 Vaccines market estimates & forecasts, 2018 - 2030 (USD Million)
  • Fig. 26 Attenuated vaccines market estimates & forecasts, 2018 - 2030 (USD Million)
  • Fig. 27 Inactivated vaccines market estimates & forecasts, 2018 - 2030 (USD Million)
  • Fig. 28 Subunit vaccines market estimates & forecasts, 2018 - 2030 (USD Million)
  • Fig. 29 DNA vaccines market estimates & forecasts, 2018 - 2030 (USD Million)
  • Fig. 30 Recombinant vaccines market estimates & forecasts, 2018 - 2030 (USD Million)
  • Fig. 31 Autogenous vaccines market estimates & forecasts, 2018 - 2030 (USD Million)
  • Fig. 32 Other biologics market estimates & forecasts, 2018 - 2030 (USD Million)
  • Fig. 33 Pharmaceuticals market estimates & forecasts, 2018 - 2030 (USD Million)
  • Fig. 34 Parasiticides market estimates & forecasts, 2018 - 2030 (USD Million)
  • Fig. 35 Anti-infectives market estimates & forecasts, 2018 - 2030 (USD Million)
  • Fig. 36 Anti-inflammatory market estimates & forecasts, 2018 - 2030 (USD Million)
  • Fig. 37 Analgesics market estimates & forecasts, 2018 - 2030 (USD Million)
  • Fig. 38 Other market estimates & forecasts, 2018 - 2030 (USD Million)
  • Fig. 39 Medicinal feed additives market estimates & forecasts, 2018 - 2030 (USD Million)
  • Fig. 40 U.S. animal health market by animal type: Key takeaways
  • Fig. 41 U.S. animal health market by animal type market share, 2023 & 2030
  • Fig. 42 Production animal market estimates & forecasts, 2018 - 2030 (USD Million)
  • Fig. 43 Swine market estimates & forecasts, 2018 - 2030 (USD Million)
  • Fig. 44 Poultry market estimates & forecasts, 2018 - 2030 (USD Million)
  • Fig. 45 Cattle market estimates & forecasts, 2018 - 2030 (USD Million)
  • Fig. 46 Sheep & goats market estimates & forecasts, 2018 - 2030 (USD Million)
  • Fig. 47 Fish market estimates & forecasts, 2018 - 2030 (USD Million)
  • Fig. 48 Companion animal market estimates & forecasts, 2018 - 2030 (USD Million)
  • Fig. 49 Dogs market estimates & forecasts, 2018 - 2030 (USD Million)
  • Fig. 50 Cats market estimates & forecasts, 2018 - 2030 (USD Million)
  • Fig. 51 Horses market estimates & forecasts, 2018 - 2030 (USD Million)
  • Fig. 52 Other market estimates & forecasts, 2018 - 2030 (USD Million)
  • Fig. 53 U.S. animal health market by type of vaccine: Key takeaways
  • Fig. 54 U.S. animal health market by type of vaccine market share, 2024 & 2030
  • Fig. 55 Cattle vaccine market estimates & forecasts, 2018 - 2030 (USD Million)
  • Fig. 56 Porcine vaccine market estimates & forecasts, 2018 - 2030 (USD Million)
  • Fig. 57 Poultry vaccine market estimates & forecasts, 2018 - 2030 (USD Million)
  • Fig. 58 Aquaculture vaccine market estimates & forecasts, 2018 - 2030 (USD Million)
  • Fig. 59 Other vaccines market estimates & forecasts, 2018 - 2030 (USD Million)
  • Fig. 60 U.S. animal health market by Disease: Key takeaways
  • Fig. 61 U.S. animal health market by disease market share, 2024 & 2030
  • Fig. 62 Porcine disease market estimates & forecasts, 2018 - 2030 (USD Million)
  • Fig. 63 Poultry diseases market estimates & forecasts, 2018 - 2030 (USD Million)
  • Fig. 64 Cattle diseases market estimates & forecasts, 2018 - 2030 (USD Million)
  • Fig. 65 Aquaculture diseases market estimates & forecasts, 2018 - 2030 (USD Million)
  • Fig. 66 Other diseases market estimates & forecasts, 2018 - 2030 (USD Million)
  • Fig. 67 U.S. animal health market by Route of administration: Key takeaways
  • Fig. 68 U.S. animal health market by Route of administration, market share, 2024 & 2030
  • Fig. 69 Oral market, 2018 - 2030 (USD Million)
  • Fig. 70 Injectable market, 2018 - 2030 (USD Million)
  • Fig. 71 Subcutaneous market estimates & forecasts, 2018 - 2030 (USD Million)
  • Fig. 72 Intramuscular market estimates & forecasts, 2018 - 2030 (USD Million)
  • Fig. 73 Intravenous market estimates & forecasts, 2018 - 2030 (USD Million)
  • Fig. 74 Topical market, 2018 - 2030 (USD Million)
  • Fig. 75 Other market, 2018 - 2030 (USD Million)
  • Fig. 76 U.S. animal health market by distribution channel: Key takeaways
  • Fig. 77 U.S. Animal Health market by distribution channel market share, 2024 & 2030
  • Fig. 78 Retail market estimates & forecasts, 2018 - 2030 (USD Million)
  • Fig. 79 E-Commerce market estimates & forecasts, 2018 - 2030 (USD Million)
  • Fig. 80 Hospital/Clinic Pharmacy market estimates & forecasts, 2018 - 2030 (USD Million)
  • Fig. 81 Market participant categorization
  • Fig. 82 Heat map analysis
  • Fig. 83 Key strategies deployed by market players